Abstract:BackgroundPancreatic ductal adenocarcinoma (PDAC) is one of the deadliest solid tumors. The rapid progression of PDAC results in an advanced stage of patients when diagnosed. However, the dynamic molecular mechanism underlying PDAC progression remains far from clear.MethodsThe microarray GSE62165 containing PDAC staging samples was obtained from Gene Expression Omnibus and the differentially expressed genes (DEGs) between normal tissue and PDAC of different stages were profiled using R software, respectively. The software program Short Time-series Expression Miner was applied to cluster, compare, and visualize gene expression differences between PDAC stages. Then, function annotation and pathway enrichment of DEGs were conducted by Database for Annotation Visualization and Integrated Discovery. Further, the Cytoscape plugin DyNetViewer was applied to construct the dynamic protein-protein interaction networks and to analyze different topological variation of nodes and clusters over time. The phosphosite markers of stage-specific protein kinases were predicted by PhosphoSitePlus database. Moreover, survival analysis of candidate genes and pathways was performed by Kaplan-Meier plotter. Finally, candidate genes were validated by immunohistochemistry in PDAC tissues.ResultsCompared with normal tissues, the total DEGs number for each PDAC stage were 994 (stage I), 967 (stage IIa), 965 (stage IIb), 1027 (stage III), 925 (stage IV), respectively. The stage-course gene expression analysis showed that 30 distinct expressional models were clustered. Kyoto Encyclopedia of Genes and Genomes analysis indicated that the up-regulated DEGs were commonly enriched in five fundamental pathways throughout five stages, including pathways in cancer, small cell lung cancer, ECM-receptor interaction, amoebiasis, focal adhesion. Except for amoebiasis, these pathways were associated with poor PDAC overall survival. Meanwhile, LAMA3, LAMB3, LAMC2, COL4A1 and FN1 were commonly shared by these five pathways and were unfavorable factors for prognosis. Furthermore, by constructing the stage-course dynamic protein interaction network, 45 functional molecular modules and 19 nodes were identified as featured regulators for all PDAC stages, among which the collagen family and integrins were considered as two main regulators for facilitating aggressive progression. Additionally, the clinical relevance analysis suggested that the stage IV featured nodes MLF1IP and ITGB4 were significantly correlated with shorter overall survival. Moreover, 15 stage-specific protein kinases were identified from the dynamic network and CHEK1 was particularly activated at stage IV. Experimental validation showed that MLF1IP, LAMA3 and LAMB3 were progressively increased from tumor initiation to progression.ConclusionsOur study provided a view for a better understanding of the dynamic landscape of molecular interaction networks during PDAC progression and offered potential targets for therapeutic intervention.

Application of TEM: Dynamic changes of AKAP95-Cx43 complex during G1 phase of lung cancer cells

AKAP95 transports Cx43 into nucleus, regulating G1/S transition of A549 cells.

Dynamic changes in protein interaction between AKAP95 and Cx43 during cell cycle progression of A549 cells

Cx43 and AKAP95 Regulate G1/S Conversion by Competitively Binding to Cyclin E1/E2 in Lung Cancer Cells

AKAP95 regulates ubiquitination and degradation of cyclin Ds/Es, influencing the G1/S transition of lung cancer cells

AKAP95 Promotes Cell Cycle Progression Via Interactions with Cyclin E and Low Molecular Weight Cyclin E.

Epac1 is Involved in Cell Cycle Progression in Lung Cancer Through PKC and Cx43 Regulation

Expression of A-kinase Anchor Protein 95, Cyclin E2, and Connexin 43 in Lung Cancer Tissue, Clinical Significance of Their Expression, and Their Expression Correlation

Roles of Cx43 and AKAP95 in Ovarian Cancer Tissues in G1/S Phase.

Correlation Analysis Between The Protein Expression Of Akap95, Cycline, And Cx43 In Breast Cancer

Correlation Between the Protein Expression Levels of A-kinase Anchor Protein95, P-Retinoblastoma (ser780), Cyclin D2/3, and Cyclin E2 in Esophageal Cancer Tissues

Analysis of Dynamic Molecular Networks for Pancreatic Ductal Adenocarcinoma Progression

Relationship Between AKAP95, Cyclin E1, Cyclin D1, and Clinicopathological Parameters in Lung Cancer Tissue

Epac1, PDE4, and PKC protein expression and their association with AKAP95, Cx43, and cyclinD2/E1 in breast cancer tissues.

Timely monitoring of the activation of Xiaoaiping-induced cysteine aspartase 3 in human lung adenocarcinoma cells by fluorescence resonance energy transfer technology

Correlation Between the Protein Expression of A-kinase Anchor Protein 95, Cyclin D3 and AKT and Pathological Indicators in Lung Cancer Tissues.

Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma

Overexpression and biological function of TMEM48 in non-small cell lung carcinoma

Synergistic Effects of AKAP95, Cyclin D1, Cyclin E1, and Cx43 in the Development of Rectal Cancer.

Increased Kif15 Expression Predicts A Poor Prognosis In Patients With Lung Adenocarcinoma

The actin cytoskeleton: Morphological changes in pre- and fully developed lung cancer